Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Summary

Madrigal Pharmaceuticals (Nasdaq: MDGL) has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The event is scheduled for Thursday, September 5, 2024, at 10:45 A.M. ET. Investors and interested parties can access the live webcast of Madrigal's presentation through a provided link or by visiting the company's Investor Relations Events page.

This conference participation offers an opportunity for Madrigal to showcase its latest developments and engage with the investment community. The company's involvement in such a prestigious healthcare event highlights its commitment to transparency and shareholder communication. For those unable to attend the live presentation, a replay of the webcast will be made available after the event, ensuring widespread access to the information shared during the conference.

News Market Reaction

+1.21%

1 alert

+1.21% News Effect

On the day this news was published, MDGL gained 1.21%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

CONSHOHOCKEN, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Morgan Stanley 22^nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 10:45 A.M. ET.

The presentation will be webcast live and may be accessed here or by visiting Madrigal’s Investor Relations Events page. A replay of the webcast will be available after the event.

About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of NASH. For more information, visit www.madrigalpharma.com.

Investor Contact
Tina Ventura, IR@madrigalpharma.com

Media Contact
Christopher Frates, media@madrigalpharma.com

FAQ

When is Madrigal Pharmaceuticals (MDGL) presenting at the Morgan Stanley Healthcare Conference?

Madrigal Pharmaceuticals (MDGL) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024, at 10:45 A.M. ET.

How can investors access Madrigal Pharmaceuticals' (MDGL) presentation at the Morgan Stanley conference?

Investors can access the live webcast of Madrigal Pharmaceuticals' (MDGL) presentation through a link provided by the company or by visiting Madrigal's Investor Relations Events page.

Will there be a replay available of Madrigal Pharmaceuticals' (MDGL) Morgan Stanley conference presentation?

Yes, a replay of the webcast will be available after the event for those who cannot attend the live presentation of Madrigal Pharmaceuticals (MDGL) at the Morgan Stanley conference.

What is the significance of Madrigal Pharmaceuticals (MDGL) participating in the Morgan Stanley Healthcare Conference?

Madrigal Pharmaceuticals' (MDGL) participation in the Morgan Stanley Healthcare Conference provides an opportunity for the company to showcase its developments, engage with investors, and demonstrate its commitment to transparency and shareholder communication.